Please login to the form below

Not currently logged in
Email:
Password:

Ad26

This page shows the latest Ad26 news and features for those working in and with pharma, biotech and healthcare.

HIV vaccine from J&J starts human trials

HIV vaccine from J&J starts human trials

In the case of J&J's vaccine, the regimen is an adenovirus serotype 26 (Ad26) vectored vaccine to prime the immune system, followed by a boost with a purified HIV

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Consulting at McCann Health

We are the strategic consultancy of McCann Health. We combine fresh and creative thinking with scientific and strategic depth...

Latest intelligence

No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...

Infographics